AllianceBernstein’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-32,700
| Closed | -$322K | – | 3203 |
|
|
2023
Q1 | $322K | Buy |
32,700
+3,817
| +13% | +$65.1K | ﹤0.01% | 2749 |
|
|
2022
Q4 | $541K | Buy |
28,883
+5,516
| +24% | +$125K | ﹤0.01% | 2588 |
|
|
2022
Q3 | $484K | Hold |
23,367
| – | – | ﹤0.01% | 2664 |
|
|
2022
Q2 | $485K | Hold |
23,367
| – | – | ﹤0.01% | 2700 |
|
|
2022
Q1 | $1.01M | Sell |
23,367
-16,591
| -42% | -$747K | ﹤0.01% | 2431 |
|
|
2021
Q4 | $2.39M | Buy |
39,958
+16,666
| +72% | +$1.34M | ﹤0.01% | 2028 |
|
|
2021
Q3 | $2M | Sell |
23,292
-2,916
| -11% | -$293K | ﹤0.01% | 2170 |
|
|
2021
Q2 | $2.92M | Buy |
26,208
+7,966
| +44% | +$765K | ﹤0.01% | 1950 |
|
|
2021
Q1 | $2.03M | Buy |
18,242
+350
| +2% | +$46K | ﹤0.01% | 2093 |
|
|
2020
Q4 | $1.9M | Hold |
17,892
| – | – | ﹤0.01% | 2015 |
|
|
2020
Q3 | $2.49M | Sell |
17,892
-3,761
| -17% | -$784K | ﹤0.01% | 1729 |
|
|
2020
Q2 | $7M | Buy |
21,653
+11,403
| +111% | +$1.83M | ﹤0.01% | 1155 |
|
|
2020
Q1 | $915K | Sell |
10,250
-3,500
| -25% | -$216K | ﹤0.01% | 2072 |
|
|
2019
Q4 | $545K | Hold |
13,750
| – | – | ﹤0.01% | 2515 |
|
|
2019
Q3 | $338K | Hold |
13,750
| – | – | ﹤0.01% | 2757 |
|
|
2019
Q2 | $485K | Buy |
13,750
+3,775
| +38% | +$150K | ﹤0.01% | 2618 |
|
|
2019
Q1 | $446K | Sell |
9,975
-258
| -3% | -$13K | ﹤0.01% | 2560 |
|
|
2018
Q4 | $491K | Buy |
10,233
+758
| +8% | +$46K | ﹤0.01% | 2493 |
|
|
2018
Q3 | $632K | Sell |
9,475
-575
| -6% | -$32K | ﹤0.01% | 2530 |
|
|
2018
Q2 | $473K | Buy |
10,050
+1,417
| +16% | +$78.2K | ﹤0.01% | 2632 |
|
|
2018
Q1 | $488K | Buy |
8,633
+1,541
| +22% | +$83.4K | ﹤0.01% | 2523 |
|
|
2017
Q4 | $351K | Hold |
7,092
| – | – | ﹤0.01% | 2660 |
|
|
2017
Q3 | $540K | Sell |
7,092
-866
| -11% | -$64.4K | ﹤0.01% | 2540 |
|
|
2017
Q2 | $749K | Buy |
7,958
+1,533
| +24% | +$131K | ﹤0.01% | 2449 |
|
|
2017
Q1 | $510K | Sell |
6,425
-1,542
| -19% | -$123K | ﹤0.01% | 2530 |
|
|
2016
Q4 | $663K | Hold |
7,967
| – | – | ﹤0.01% | 2454 |
|
|
2016
Q3 | $891K | Hold |
7,967
| – | – | ﹤0.01% | 2286 |
|
|
2016
Q2 | $883K | Buy |
7,967
+2,042
| +34% | +$248K | ﹤0.01% | 2281 |
|
|
2016
Q1 | $619K | Sell |
5,925
-933
| -14% | -$72K | ﹤0.01% | 2336 |
|
|
2015
Q4 | $553K | Hold |
6,858
| – | – | ﹤0.01% | 2412 |
|
|
2015
Q3 | $476K | Hold |
6,858
| – | – | ﹤0.01% | 2505 |
|
|
2015
Q2 | $672K | Hold |
6,858
| – | – | ﹤0.01% | 2474 |
|
|
2015
Q1 | $672K | Hold |
6,858
| – | – | ﹤0.01% | 2371 |
|
|
2014
Q4 | $756K | Sell |
6,858
-150
| -2% | -$18.3K | ﹤0.01% | 2348 |
|
|
2014
Q3 | $828K | Hold |
7,008
| – | – | ﹤0.01% | 2301 |
|
|
2014
Q2 | $909K | Buy |
7,008
+6,955
| +13,123% | +$821K | ﹤0.01% | 2306 |
|
|
2014
Q1 | $8K | Sell |
53
-41
| -44% | -$5.88K | ﹤0.01% | 3295 |
|
|
2013
Q4 | $13K | Buy |
94
+83
| +755% | +$8.31K | ﹤0.01% | 3092 |
|
|
2013
Q3 | $1K | Buy |
+11
| New | +$922 | ﹤0.01% | 3363 |
|
Other funds holding INO
AllianceBernstein's INO Position: Q2 2023 in Review
AllianceBernstein sold out of Inovio Pharmaceuticals (INO) in Q2 2023, closing a stake of 32,700 shares — an estimated $322K sold.
AllianceBernstein first reported a position in INO in Q3 2013 and held it in 39 quarters. The position peaked at $7M in Q2 2020. 133 funds tracked by Wall St. Rank hold INO as of Q2 2023.
- AllianceBernstein reported no remaining Inovio Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
- AllianceBernstein sold 32,700 Inovio Pharmaceuticals shares in Q2 2023, an estimated $322K.
- AllianceBernstein first reported a position in Inovio Pharmaceuticals in Q3 2013 and held it in 39 quarters.
- AllianceBernstein's Inovio Pharmaceuticals position peaked at $7M in Q2 2020.
- 133 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q2 2023.
Based on AllianceBernstein's 13F filing for Q2 2023, filed 15 Aug 2023.